A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise Alone (SURPASS-1)

I8F-MC-GPGK -

The goal for this study is to evaluate the efficacy and safety of tirzepatide versus placebo in participants with type 2 diabetes not under control with diet and exercise alone.

Trial Summary

Age Range
≥18 years
Conditions the trial is for
Type 2 Diabetes
What the trial is testing?
Tirzepatide
Could I receive a Placebo?
Yes
Enrollment Goal
478
Trial Dates
Jun 3, 2019 - Oct 28, 2020
How long will I be in the trial?
The study will last approximately 47 weeks and may include about 15 visits.
Trial Phase
III

Lilly Trial Alerts

Not the right fit? Sign up to receive updates about new trials that are listed or when a new trial site begins enrolling near you.